299 related articles for article (PubMed ID: 16139136)
1. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation.
Goldberger Z; Elbel B; McPherson CA; Paltiel AD; Lampert R
J Am Coll Cardiol; 2005 Sep; 46(5):850-7. PubMed ID: 16139136
[TBL] [Abstract][Full Text] [Related]
2. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
4. Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.
Deniz HB; Caro JJ; Ward A; Moller J; Malik F
J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):43-50. PubMed ID: 18268418
[TBL] [Abstract][Full Text] [Related]
5. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
7. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator].
Kazmierczak J; Tavernier R; De Sutter J; Jordaens L
Pol Merkur Lekarski; 2000 Aug; 9(50):522-6. PubMed ID: 11081315
[TBL] [Abstract][Full Text] [Related]
9. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
[TBL] [Abstract][Full Text] [Related]
10. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
11. Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator.
Krahn AD; Hoch JS; Rockx MA; Leong-Sit P; Gula LJ; Yee R; Skanes AC; Klein GJ
Am J Cardiol; 2008 Sep; 102(5):588-92. PubMed ID: 18721517
[TBL] [Abstract][Full Text] [Related]
12. Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre.
Fanourgiakis J; Simantirakis E; Maniadakis N; Kourlaba G; Kanoupakis E; Chrysostomakis S; Vardas P
Europace; 2013 Mar; 15(3):366-75. PubMed ID: 23148117
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunction.
Rinfret S; Cohen DJ; Lamas GA; Fleischmann KE; Weinstein MC; Orav J; Schron E; Lee KL; Goldman L
Circulation; 2005 Jan; 111(2):165-72. PubMed ID: 15630030
[TBL] [Abstract][Full Text] [Related]
14. Economic analysis of a randomized trial of biventricular pacing in Canada.
Bentkover JD; Dorian P; Thibault B; Gardner M
Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
[TBL] [Abstract][Full Text] [Related]
15. Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome without atrioventricular block: a systematic review and economic evaluation.
Edwards SJ; Karner C; Trevor N; Wakefield V; Salih F
Health Technol Assess; 2015 Aug; 19(65):1-210. PubMed ID: 26293406
[TBL] [Abstract][Full Text] [Related]
16. Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
Ricci RP; Quesada A; Almendral J; Arribas F; Wolpert C; Adragao P; Zoni-Berisso M; Navarro X; DeSanto T; Grammatico A; Santini M;
Europace; 2009 May; 11(5):587-93. PubMed ID: 19401341
[TBL] [Abstract][Full Text] [Related]
17. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.
Day JD; Olshansky B; Moore S; Brown S; Stolen KQ; Lerew DR;
Europace; 2008 Mar; 10(3):347-50. PubMed ID: 18308755
[TBL] [Abstract][Full Text] [Related]
18. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
19. Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009).
Tuppin P; Neumann A; Marijon E; de Peretti C; Weill A; Ricordeau P; Danchin N; Allemand H
Arch Cardiovasc Dis; 2011 May; 104(5):332-42. PubMed ID: 21693370
[TBL] [Abstract][Full Text] [Related]
20. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
